These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21824195)

  • 41. Transcriptional profiling of liver and effect of glucocorticoids in a rat adjuvant-induced arthritis model.
    Song YL; Foster WR; Shuster DJ; Nadler SG; Salter-Cid L; Sasseville VG
    Vet Pathol; 2011 Jul; 48(4):885-95. PubMed ID: 21149847
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Irrational use of skin-bleaching products can delay the diagnosis of leprosy.
    Mahé A; Ly F; Badiane C; Baldé Y; Dangou JM
    Int J Lepr Other Mycobact Dis; 2002 Jun; 70(2):119-21. PubMed ID: 12211896
    [No Abstract]   [Full Text] [Related]  

  • 43. Side effects of topical glucocorticoids.
    Mills CM; Marks R
    Curr Probl Dermatol; 1993; 21():122-31. PubMed ID: 8299365
    [No Abstract]   [Full Text] [Related]  

  • 44. Suppression of hyaluronan synthase 2 expression reflects the atrophogenic potential of glucocorticoids.
    Averbeck M; Gebhardt C; Anderegg U; Simon JC
    Exp Dermatol; 2010 Aug; 19(8):757-9. PubMed ID: 20659158
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hazards of potent topical corticosteroids.
    Lancet; 1973 Apr; 1(7808):870-1. PubMed ID: 4123412
    [No Abstract]   [Full Text] [Related]  

  • 46. Skin atrophy of the eyelid induced by topical ophthalmic corticosteroids.
    Neittaanmäki H; Kontkanen M; Kallioinen M
    Acta Ophthalmol Scand; 1998 Jun; 76(3):372-3. PubMed ID: 9686858
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New aspects of the mechanism of corticosteroid-induced dermal atrophy.
    Oikarinen A; Autio P
    Clin Exp Dermatol; 1991 Nov; 16(6):416-9. PubMed ID: 1806315
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Glucocorticoid-induced cutaneous adverse events].
    Guillot B
    Rev Med Interne; 2013 May; 34(5):310-4. PubMed ID: 23312116
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Skin Anti-Inflammatory Potential with Reduced Side Effects of Novel Glucocorticoid Receptor Agonists.
    Flori E; Mosca S; Kovacs D; Briganti S; Ottaviani M; Mastrofrancesco A; Truglio M; Picardo M
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203435
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The hairless mouse model for assaying the atrophogenicity of topical corticosteroids.
    Woodbury R; Kligman AM
    Acta Derm Venereol; 1992 Nov; 72(6):403-6. PubMed ID: 1362829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of Persistent Cutaneous Atrophy After Corticosteroid Injection With Fat Graft.
    Martins N; Polido-Pereira J; Caneira M; Fonseca JE
    Reumatol Clin (Engl Ed); 2019; 15(6):e122-e124. PubMed ID: 29229449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Test systems for the determination of glucocorticoid receptor ligand induced skin atrophy.
    Schoepe S; Schäcke H; Asadullah K
    Dermatoendocrinol; 2011 Jul; 3(3):175-9. PubMed ID: 22110776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of glucocorticoid-induced epidermal and dermal atrophy with KH 1060--a potent 20-epi analogue of 1,25-dihydroxyvitamin D3.
    Gniadecki R; Gniadecka M; Serup J
    Br J Pharmacol; 1994 Oct; 113(2):439-44. PubMed ID: 7834193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atrophy of the skin. The clinical problems.
    Sneddon IB
    Br J Dermatol; 1976 Mar; 94 suppl 12():121-3. PubMed ID: 1268072
    [No Abstract]   [Full Text] [Related]  

  • 55. Understanding the side effects of glucocorticoid therapy: shining a light on a drug everyone thinks they know.
    Dixon WG; Bansback N
    Ann Rheum Dis; 2012 Nov; 71(11):1761-4. PubMed ID: 22851467
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Iatrogenic alterations of the biomechanical properties of human skin.
    Pierard GE
    Br J Dermatol; 1978 Jan; 98(1):113-4. PubMed ID: 626710
    [No Abstract]   [Full Text] [Related]  

  • 57. [This is how I deal with corticosteroid-induced skin atrophy].
    Mrowietz U
    Z Rheumatol; 2023 Nov; 82(9):784-786. PubMed ID: 37695545
    [No Abstract]   [Full Text] [Related]  

  • 58. Glucocorticoid-Induced Skin Atrophy: The Old and the New.
    Niculet E; Bobeica C; Tatu AL
    Clin Cosmet Investig Dermatol; 2020; 13():1041-1050. PubMed ID: 33408495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidermal thinning atrophy of the skin and tropical steroids.
    Wilson L
    Int J Dermatol; 1978 Mar; 17(2):137-8. PubMed ID: 649245
    [No Abstract]   [Full Text] [Related]  

  • 60. What's your assessment?
    Bielan B
    Dermatol Nurs; 2002 Jun; 14(3):182-3. PubMed ID: 12099067
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.